PreciseDx collects $10.75m

PreciseDx, a cancer risk stratification company. has raised $10.75 million in funding.

PreciseDx, a cancer risk stratification company. has raised $10.75 million in funding. Merck Global Health Innovation Fund led the round.

Source: Press Release